Eric M. Verdin
Impact in
- Geriatrics and Gerontology top 0.01%
- Sirtuins and Resveratrol in Medicine
- Virology top 0.05%
- HIV Research and Treatment
Papers in
-
- Sirtuins and Resveratrol in Medicine 90
- Virology 71
- HIV Research and Treatment 71
- Co-authors
- Mélanie Ott (32 shared papers)Brian J. North (13 shared papers)Matthew D. Hirschey (18 shared papers)Carine M. Van Lint (18 shared papers)Wolfgang Fischle (16 shared papers)Stéphane Emiliani (11 shared papers)Bjoern Schwer (8 shared papers)Samuel Dequiedt (12 shared papers)
- Journals
- Journal of Biological Chemistry (17 papers)Journal of Virology (17 papers)Aging (12 papers)Proceedings of the National Academy of Sciences (12 papers)Cell Metabolism (12 papers)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Eric M. Verdin
313 papers receiving 58.5k citations
Eric M. Verdin's Hit Papers
Peers
Comparison fields: 5 of 192
- Geriatrics and Gerontology 12.3k
- Virology 7.6k
- Aging 1.9k
- Physiology 2.8k
- Physiology 12.3k
Countries citing papers authored by Eric M. Verdin
This map shows the geographic impact of Eric M. Verdin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Verdin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Verdin more than expected).
Fields of papers citing papers by Eric M. Verdin
This network shows the impact of papers produced by Eric M. Verdin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Verdin. The network helps show where Eric M. Verdin may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric M. Verdin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 320 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Chronic inflammation in the etiology of disease across the life span Hit paper breakdown → | 2019 | 3539 |
| 2 | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing Hit paper breakdown → | 2020 | 3391 |
| 3 | Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor Hit paper breakdown → | 2012 | 1478 |
| 4 | SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation Hit paper breakdown → | 2010 | 1453 |
| 5 | The Human Sir2 Ortholog, SIRT2, Is an NAD+-Dependent Tubulin Deacetylase Hit paper breakdown → | 2003 | 1324 |
| 6 | Calorie Restriction Reduces Oxidative Stress by SIRT3-Mediated SOD2 Activation Hit paper breakdown → | 2010 | 1142 |
| 7 | The growing landscape of lysine acetylation links metabolism and cell signalling Hit paper breakdown → | 2014 | 1128 |
| 8 | NAD+ metabolism and its roles in cellular processes during ageing Hit paper breakdown → | 2020 | 1123 |
| 9 | Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation Hit paper breakdown → | 2001 | 1090 |
| 10 | Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation Hit paper breakdown → | 2007 | 1078 |
| 11 | NAD + in aging, metabolism, and neurodegeneration Hit paper breakdown → | 2015 | 1063 |
| 12 | From discoveries in ageing research to therapeutics for healthy ageing Hit paper breakdown → | 2019 | 1021 |
| 13 | Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype Hit paper breakdown → | 2015 | 1015 |
| 14 | Ketone bodies as signaling metabolites Hit paper breakdown → | 2013 | 811 |
| 15 | A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases Hit paper breakdown → | 1998 | 794 |
| 16 | HIV reproducibly establishes a latent infection after acute infection of T cells in vitro Hit paper breakdown → | 2003 | 771 |
| 17 | 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond Hit paper breakdown → | 2014 | 717 |
| 18 | SIRT3 Deficiency and Mitochondrial Protein Hyperacetylation Accelerate the Development of the Metabolic Syndrome Hit paper breakdown → | 2011 | 694 |
| 19 | β-Hydroxybutyrate: A Signaling Metabolite Hit paper breakdown → | 2017 | 653 |
| 20 | The First Identification of Lysine Malonylation Substrates and Its Regulatory Enzyme Hit paper breakdown → | 2011 | 647 |
About Eric M. Verdin
Eric M. Verdin is a scholar working on Geriatrics and Gerontology, Virology, Physiology, Molecular Biology and Infectious Diseases, having authored 320 papers that have together received 59.6k indexed citations. Recurring topics across this work include Sirtuins and Resveratrol in Medicine (90 papers), HIV Research and Treatment (71 papers), Histone Deacetylase Inhibitors Research (54 papers), Adipose Tissue and Metabolism (42 papers), Immune Cell Function and Interaction (38 papers), HIV/AIDS drug development and treatment (35 papers), Protein Degradation and Inhibitors (30 papers) and Autophagy in Disease and Therapy (29 papers). The work is most often cited by research in Geriatrics and Gerontology (12.3k citations), Virology (7.6k citations), Aging (1.9k citations), Physiology (2.8k citations) and Physiology (12.3k citations). Eric M. Verdin has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Mélanie Ott, Brian J. North, Matthew D. Hirschey, Carine M. Van Lint, Wolfgang Fischle, Stéphane Emiliani, Bjoern Schwer, Samuel Dequiedt, Laura R. Saunders and Judith Campisi. Their work appears in journals such as Journal of Biological Chemistry, Journal of Virology, Aging, Proceedings of the National Academy of Sciences and Cell Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.